Online registration is now closed. Walk-ins are welcome.
Literature has shown that prescribers receive little education on the treatment of pain, resulting in less effective pain treatment with worse outcomes. Attendees will learn the evidence-based analysis of the relative effectiveness of medications and their side effects, recommendations on how to improve treatment of acute and chronic pain, and recognizing substance use/opioid use disorders. This program will include the three required topics outlined by the new CME requirement in 21 NCAC 32R .0101:
• Controlled substances prescribing practices
• Recognizing signs of the abuse or misuse of controlled substances
• Controlled substance prescribing for chronic pain management
As of July 1, 2017 all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CE requirements as set forth by their licensing boards; requirements vary by discipline and board. Physicians must follow the CME requirement per 21 NCAC 32R .0101 and will turn in record of controlled substance CME when they renew licensure.
Same course content, alternate date: October 30, 2018
MAHEC engages in evaluation activities to better understand the impact of our programs. By registering for this course, you agree that we may use your personal information in evaluative research regarding this program. Any reports published will be de-identified and reported in aggregate format.
The program is recommended for physicians, physician assistants, pharmacists, nurse practitioners, and podiatrists.
Upon completion of this knowledge based educational activity, participants will be able to:
- Describe the impact of the opioid crisis
- Identify the CDC guidelines for prescribing opioids for acute pain
- Identify the CDC guidelines for prescribing opioids for chronic pain
- Discuss what to do with patients on opioids that fall outside the guidelines
- Susan McDowell, MD